Julian Harrison's Stock Ratings

BTIG Analyst

Julian Harrison is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/28/2024

Overall Average Return

8.01%

Smart Score

Overall Average Return Percentile

56th

Number of Ratings

date ▲▼	ticker ▲▼	Buy Now	Company ▲▼	Current price ▲▼	Upside/Downside ▲▼	Analyst Firm ▲▼	Analyst & % Accurate ▲▼	Price Target Change ▲▼	Rating Change ▲▼	Previous / Current Rating ▲▼	Get Alert
04/12/2024	TBPH	Buy Now	Theravance Biopharma	$9.12	130.26%	BTIG	Julian Harrison54%	→ $21	Initiates	→ Buy	Get Alert
03/27/2024	OTLK	Buy Now	Outlook Therapeutics	$8.31	501.68%	BTIG	Julian Harrison54%	→ $50	Upgrade	Neutral → Buy	Get Alert
02/26/2024	ANAB	Buy Now	AnaptysBio	$20.50	168.29%	BTIG	Julian Harrison54%	→ $55	Initiates	→ Buy	Get Alert
02/13/2024	CBAY	Buy Now	CymaBay Therapeutics	—	—	BTIG	Julian Harrison54%	—	Downgrade	Buy → Neutral	Get Alert
01/11/2024	ACRS	Buy Now	Aclaris Therapeutics	$1.20	—	BTIG	Julian Harrison54%	—	Downgrade	Buy → Neutral	Get Alert
12/20/2023	SYRE	Buy Now	Spyre Therapeutics	$33.56	-4.65%	BTIG	Julian Harrison54%	→ $32	Initiates	→ Buy	Get Alert
12/20/2023	APGE	Buy Now	Apogee Therapeutics	$47.13	-8.76%	BTIG	Julian Harrison54%	→ $43	Initiates	→ Buy	Get Alert
11/29/2023	AKBA	Buy Now	Akebia Therapeutics	$1.33	200.68%	BTIG	Julian Harrison54%	→ $4	Assumes	→ Buy	Get Alert
10/11/2023	MTNB	Buy Now	Matinas BioPharma Hldgs	$0.18	1573.17%	BTIG	Julian Harrison54%	$3 → $3	Reinstates	Buy → Buy	Get Alert
09/25/2023	MORF	Buy Now	Morphic Holding	$27.51	—	BTIG	Julian Harrison54%	—	Downgrade	Buy → Neutral	Get Alert
09/08/2023	CBAY	Buy Now	CymaBay Therapeutics	—	—	BTIG	Julian Harrison54%	$22 → $24	Maintains	Buy	Get Alert
08/30/2023	OTLK	Buy Now	Outlook Therapeutics	$8.31	—	BTIG	Julian Harrison54%	—	Downgrade	Buy → Neutral	Get Alert
08/11/2023	CBAY	Buy Now	CymaBay Therapeutics	—	—	BTIG	Julian Harrison54%	$18 → $22	Maintains	Buy	Get Alert
07/05/2023	CBAY	Buy Now	CymaBay Therapeutics	—	—	BTIG	Julian Harrison54%	$15 → $18	Maintains	Buy	Get Alert
07/03/2023	PTGX	Buy Now	Protagonist Therapeutics	$25.15	63.02%	BTIG	Julian Harrison54%	→ $41	Reiterates	→ Buy	Get Alert
06/14/2023	VRDN	Buy Now	Viridian Therapeutics	$12.88	257.14%	BTIG	Julian Harrison54%	→ $46	Initiates	→ Buy	Get Alert
05/15/2023	CBAY	Buy Now	CymaBay Therapeutics	—	—	BTIG	Julian Harrison54%	$15 → $15	Maintains	Buy	Get Alert
05/01/2023	CBAY	Buy Now	CymaBay Therapeutics	—	—	BTIG	Julian Harrison54%	$15 → $15	Maintains	Buy	Get Alert
03/19/2023	CBAY	Buy Now	CymaBay Therapeutics	—	—	BTIG	Julian Harrison54%	$15 → $15	Maintains	Buy	Get Alert